Celgene (CELG) Affirms $600M Acquisition of EngMab - Bloomberg, Citing Statement

September 30, 2016 12:37 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Celgene (Nasdaq: CELG) affirms earlier reports that it acquired EngMab for $600 million, according to Bloomberg, citing an emailed statement on Friday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Mergers and Acquisitions

Add Your Comment